Indeed, the treatment of ischemic pheochromocytoma cells with mesenchymal stem cells produces therapeutic effects due to IL-6 and vascular endothelial growth factor secretion [45]. The gene discussed is IL6; the disease is hereditary pheochromocytoma-paraganglioma.